The pharmaceutical landscape for diabetes is evolving, and GLP-1 patches represent a promising breakthrough. Unlike shots, this approach offers a simpler way to administer GLP-1 drugs. These patches slowly release the drug through the epidermis offering a stable amount of the beneficial agent, wh